Group 1 - The core point of the article is that Changjiang Chenda, a major shareholder of Shangtai Technology, plans to reduce its stake in the company by selling up to 5,193,925 shares within three months after a 15 trading day notice period [1] - As of the announcement, Changjiang Chenda holds approximately 19.46 million shares, representing 7.4633% of the total share capital of Shangtai Technology [1] - Shangtai Technology's revenue composition for the first half of 2025 indicates that lithium-ion battery anode materials account for 91.57% of its revenue, while carbon products and other businesses contribute 4.81% and 3.62%, respectively [1] Group 2 - The current market capitalization of Shangtai Technology is 22.1 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year, indicating a hot secondary market for biomedicine [2]
尚太科技:股东长江晨道计划减持公司股份不超过约519万股